3//SEC Filing
BIOVEST INTERNATIONAL INC 3
Accession 0001214659-13-006966
CIK 0000704384operating
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 5:05 PM ET
Size
5.1 KB
Accession
0001214659-13-006966
Insider Transaction Report
Form 3
FARRELL ROBERT EDWARD
CHIEF FINANCIAL OFFICER
Holdings
Stock Option (Right to Buy)
Exercise: $1.00Exp: 2019-12-01→ Common Stock (750,000 underlying)
Footnotes (2)
- [F1]The Options are exercisable as they vest. The Options will vest one-third on December 1, 2014, the one-year anniversary of the grant date, one-third on December 1, 2015, the two-year anniversary of the grant date, and the remaining one-third on December 1, 2016, the three-year anniversary of the grant date. Notwithstanding this vesting schedule, if there is a sale of the vaccine business, instruments business or substantially all of the assets of the Company, any unvested portion of the Options shall fully vest.
- [F2]If by December 31, 2015, all or substantially all of the assets of the Company are sold or BiovaxID? is sold, the exercise price will be reduced to $0.64 per share.
Documents
Issuer
BIOVEST INTERNATIONAL INC
CIK 0000704384
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000704384
Filing Metadata
- Form type
- 3
- Filed
- Dec 9, 7:00 PM ET
- Accepted
- Dec 10, 5:05 PM ET
- Size
- 5.1 KB